Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015

Research on the Role of Combined Chemotherapy and Radiotherapy in Patients With N+ Non-Metastatic Metaplastic Breast Carcinoma: A Competing Risk Analysis Model Based on the SEER database, 2000 to 2015

PurposeDue to the rarity of metaplastic breast carcinoma (MpBC), no randomized trials have investigated the role of combined chemotherapy and radiotherapy (CCRP) in this condition. We aimed to explore and identify the effectiveness of CCRP in patients with regional lymph node metastasis (N+) non-met...

Full description

Bibliographic Details
Main Authors: Yifei Ma, Zejian Yang, Yihan Gao, Kunlong Li, Pei Qiu, Heyan Chen, Shengyu Pu, Bo Wang, Can Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
metaplastic breast carcinoma
combined chemotherapy and radiotherapy
SEER
regional lymph node metastasis
competing risk model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.583488/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.583488/full

Similar Items